1Gibson GE, Hirsch JA, Cirio RT, et al. Abnormal thiamine-dependent processes in Alzheimer' s disease. Lessons from diabetes [J]. Mol Cell Neurosci, 2013,55 (1): 17-25.
2Rabbani N, Thornalley PJ. Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy[J]. DiabetesObesMetab, 2011, 13 (7) : 577 -583.
3Adaikalakoteswari A, Rabbani N, Waspadji S, et al. Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia-link to renal status, glycemic control and vascular inflammation [J]. Diabetes Res Clin Pract, 2012, 95 (3): 415-424.
4Page GL, Laight D, Cummings MH. Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease [J]. Int J Clin Praet,2011, 65 (6): 684-690.
5Pacal L, Tomandl J, Svojanovsky J, et al. Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy [J]. Nephrol Dial Transplant, 2011, 26 (4): 1229-1236.
6Luong KV, Nguyen LT. The impact of thiamine treatment in the diabetes mellitus[J]. J Clin Med Res, 2012, 4 (3): 153-160.
7Alkhalaf A, Klooster A, van Oeveren W, et al. A double- blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy [J]. Diabetes Care, 2010, 33 (7) : 1598-1601.
8Babaei-Jadidi R, Krarchalias N, Ahamed N, et al. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine [J]. Diabetes, 2003, 52 (8): 2110-2120.
9Riaz S, Skinner V, Srai SK. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2 [J]. J Pharm Biomed Anal, 2011, 54 (4): 817-825.
10Larkin JR, Zhang F, Godfrey L, et al. Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produeesthiamine insufficiency in diabetes[J]. PLoSOne, 2012, 7 (12): e53175.
